ReviewMolecular biology reports2025
A systematic analysis of various clonal lineages of colistin-resistant Klebsiella pneumoniae with mgrB mutations.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Klebsiella pneumoniae poses a significant health threat due to their pathogenicity and high propensity to acquire resistance to wide range of antimicrobial agents. Colistin, a non-ribosomal secondary cationic amphipathic peptide, exhibits bactericidal activity. Despite its known nephrotoxic and neurotoxic effects, colistin remains in use for treating multidrug-resistant bacterial infections. However, the widespread use of colistin has led to the global emergence of colistin-resistant K. pneumoniae strains. This review investigates the global epidemiology of various clonal lineages of colistin-resistant K. pneumoniae. A comprehensive search was conducted across various databases, including PubMed, ScienceDirect, and Google Scholar. A total of 81 distinct colistin-resistant K. pneumoniae sequence types were identified worldwide, with the highest clonal diversity observed in India and China (n = 16), followed by South Korea (n = 15), Brazil (n = 14), France and Saudi Arabia (n = 12), Nigeria (n = 11), Colombia (n = 9), and Italy and Taiwan (n = 8). eBURST analysis grouped 87 colistin-resistant sequence types into 51 singletons and 9 clonal complexes, forming 5 distinct clonal groups. The findings indicate a broad global distribution of colistin-resistant K. pneumoniae clones, marked by diverse mgrB mutations. This underscores the urgent need for robust monitoring and surveillance to curb the development and dissemination of colistin-resistant K. pneumoniae and to ensure effective infection control measures.
Indexed as
Identifiers
41085745What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.